Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 20,000 shares at $29.53 ($591K) on 2026-01-02, disclosed to the SEC on 2026-01-05.
Scheduled sale ($591k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2025-12-04 | $42K | — | Filing → |